A phase 1 dose-escalation study of XmAb® 2513 in patients with relapsed or refractory Hodgkin lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 01 October 2014 |
| Author/s |
author: Kristie A Blum Mitchell Smith |
| Publication date | October 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |